跳至主要内容
临床试验/NCT02145650
NCT02145650撤回不适用

Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs

Allergan0 个研究点开始时间: 2014年5月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
Allergan
主要终点
Investigator Assessment of Spasticity Severity using a 5-Point Scale

研究概览

简要总结

This study will examine the epidemiology (incidence and control of a disease), burden, clinical need, and treatment patterns of spasticity in patients with a diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI) for a minimum of 3 months

排除标准

  • Participation in a spasticity clinical trial in the past 5 years.

结局指标

主要结局

Investigator Assessment of Spasticity Severity using a 5-Point Scale

时间窗: Day 1

Percentage of Participants with Spasticity not Receiving Treatment

时间窗: Day 1

Spasticity Symptom Assessment Score using a 21-item Questionnaire

时间窗: Day 1

Spasticity Impact Assessment Score using a 32-item Questionnaire

时间窗: Day 1

次要结局

  • Percentage of Participants with Spasticity Receiving Treatment(Day 1)
  • Referral Patterns for Spasticity Management(Day 1)
  • Spasticity Screening Tool Score using a 13-item Questionnaire(Day 1)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验